Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-22

Clinical Trial Update: The Potential of Optical Coherence Tomography Angiography (OCTA) to Detect Early Cognitive Dysfunction in Diabetic Patients

View source ↗

Summary

A clinical trial is evaluating whether optical coherence tomography angiography (OCTA) can detect early cognitive dysfunction in people with Type 2 Diabetes Mel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dr. Sefic Eye Polylcinic and Optical Studio | Conditions: Type 2 Diabetes Mellitus Diabetic Retinopathy Cognitive Dysfunction | Status: ACTIVE_NOT_RECRUITING